Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 19155296)

1.

Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis.

Bode AM, Cho YY, Zheng D, Zhu F, Ericson ME, Ma WY, Yao K, Dong Z.

Cancer Res. 2009 Feb 1;69(3):905-13. doi: 10.1158/0008-5472.CAN-08-3263. Epub 2009 Jan 20.

2.

TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling.

Li S, Bode AM, Zhu F, Liu K, Zhang J, Kim MO, Reddy K, Zykova T, Ma WY, Carper AL, Langfald AK, Dong Z.

Carcinogenesis. 2011 May;32(5):779-85. doi: 10.1093/carcin/bgr037. Epub 2011 Feb 23.

3.

Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1.

Hwang MK, Bode AM, Byun S, Song NR, Lee HJ, Lee KW, Dong Z.

Cancer Res. 2010 Sep 1;70(17):6859-69. doi: 10.1158/0008-5472.CAN-09-4393. Epub 2010 Jul 26.

4.

Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.

Niiyama Y, Kawamata T, Yamamoto J, Omote K, Namiki A.

Neuroscience. 2007 Aug 24;148(2):560-72. Epub 2007 Jul 25.

PMID:
17656027
5.

Negative feedback mechanisms surpass the effect of intrinsic EGFR activation during skin chemical carcinogenesis.

Dahlhoff M, Rose C, de Angelis MH, Wolf E, Schneider MR.

Am J Pathol. 2012 Apr;180(4):1378-85. doi: 10.1016/j.ajpath.2011.12.017. Epub 2012 Feb 1.

6.

Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.

Kiguchi K, Kitamura T, Moore T, Rumi M, Chang HC, Treece D, Ruffino L, Connolly K, DiGiovanni J.

Cancer Prev Res (Phila). 2010 Aug;3(8):940-52. doi: 10.1158/1940-6207.CAPR-10-0010. Epub 2010 Aug 3.

7.

Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.

Duan L, Miura Y, Dimri M, Majumder B, Dodge IL, Reddi AL, Ghosh A, Fernandes N, Zhou P, Mullane-Robinson K, Rao N, Donoghue S, Rogers RA, Bowtell D, Naramura M, Gu H, Band V, Band H.

J Biol Chem. 2003 Aug 1;278(31):28950-60. Epub 2003 May 18.

8.

Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk.

Moore T, Beltran L, Carbajal S, Hursting SD, DiGiovanni J.

Cancer Prev Res (Phila). 2012 Oct;5(10):1236-46. doi: 10.1158/1940-6207.CAPR-12-0234. Epub 2012 Aug 15.

9.

Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.

Yang H, Wang Z, Capó-Aponte JE, Zhang F, Pan Z, Reinach PS.

Exp Eye Res. 2010 Sep;91(3):462-71. doi: 10.1016/j.exer.2010.06.022. Epub 2010 Jul 7.

10.

Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.

Sévère N, Dieudonné FX, Marty C, Modrowski D, Patiño-García A, Lecanda F, Fromigué O, Marie PJ.

J Bone Miner Res. 2012 Oct;27(10):2108-17. doi: 10.1002/jbmr.1667.

PMID:
22623369
11.

Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.

Yang Y, Yang H, Wang Z, Varadaraj K, Kumari SS, Mergler S, Okada Y, Saika S, Kingsley PJ, Marnett LJ, Reinach PS.

Cell Signal. 2013 Feb;25(2):501-11. doi: 10.1016/j.cellsig.2012.10.015. Epub 2012 Nov 8.

12.

Identification of voltage-gated K(+) channel beta 2 (Kvβ2) subunit as a novel interaction partner of the pain transducer Transient Receptor Potential Vanilloid 1 channel (TRPV1).

Bavassano C, Marvaldi L, Langeslag M, Sarg B, Lindner H, Klimaschewski L, Kress M, Ferrer-Montiel A, Knaus HG.

Biochim Biophys Acta. 2013 Dec;1833(12):3166-75. doi: 10.1016/j.bbamcr.2013.09.001. Epub 2013 Sep 11.

13.
14.

Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.

Zhong B, Wang DH.

Am J Physiol Regul Integr Comp Physiol. 2009 Dec;297(6):R1681-90. doi: 10.1152/ajpregu.90746.2008. Epub 2009 Oct 7.

15.

Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.

Ching LC, Kou YR, Shyue SK, Su KH, Wei J, Cheng LC, Yu YB, Pan CC, Lee TS.

Cardiovasc Res. 2011 Aug 1;91(3):492-501. doi: 10.1093/cvr/cvr104. Epub 2011 Apr 14.

16.

Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Dai C, Whitesell L, Rogers AB, Lindquist S.

Cell. 2007 Sep 21;130(6):1005-18.

18.

Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.

Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, Studer V, Bernardi G, Haji N, Sepman H, Fresegna D, Maccarrone M, Mandolesi G, Centonze D.

Neurobiol Dis. 2011 Sep;43(3):669-77. doi: 10.1016/j.nbd.2011.05.018. Epub 2011 Jun 6.

PMID:
21672630
19.

c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes.

Ravid T, Heidinger JM, Gee P, Khan EM, Goldkorn T.

J Biol Chem. 2004 Aug 27;279(35):37153-62. Epub 2004 Jun 21.

20.

Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis.

de Jong PR, Takahashi N, Harris AR, Lee J, Bertin S, Jeffries J, Jung M, Duong J, Triano AI, Lee J, Niv Y, Herdman DS, Taniguchi K, Kim CW, Dong H, Eckmann L, Stanford SM, Bottini N, Corr M, Raz E.

J Clin Invest. 2014 Sep;124(9):3793-806. doi: 10.1172/JCI72340. Epub 2014 Aug 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk